GW PHARMA
GW Pharma focuses on the development and commercialization of innovative drugs for indications in the mental area (CNS), and hopes to provide faster, more effective and safer treatments for unmet needs in the clinical antidepressant field. drug. The team members have rich experience in CNS new drug research and development, and product pipelines are arranged around depression and anxiety. The current data of the company's core products proves that it has obvious safety advantages compared with the products already on the market.
GW PHARMA
Industry:
Health Care
Founded:
2016-01-01
Address:
Beijing, Beijing, China
Country:
China
Status:
Active
Total Funding:
0
Similar Organizations
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Investors List
Dynamic Balance Capital
Dynamic Balance Capital investment in Seed Round - GW Pharma
Tengye Ventures
Tengye Ventures investment in Seed Round - GW Pharma